Day: March 24, 2020
SEATTLE, March 24, 2020 (GLOBE NEWSWIRE) — Jones Soda Co. (the “Company”) (OTCQB: JSDA), a leader in the craft soda industry, known for its unique branding and authentic connection to its consumers, announced results for the fourth quarter and full year ended December 31, 2019.Fourth Quarter 2019 Financial Summary vs. Year-Ago QuarterRevenue was $2.2 million compared to $2.3 million.Gross profit as a percentage of sales was 17.2% compared to 17.9%.Net loss was $930,000, or $(0.02) per share, compared to a net loss of $822,000, or $(0.02) per share.Adjusted EBITDA1 was $(828,000) compared to $(674,000).Full Year 2019 Financial Summary vs. Year Ago Revenue was $11.5 million compared to $12.6 million.Gross profit as a percentage of sales was 20.7% compared to 21.8%.Net loss was $2.8 million, or $(0.05) per share, compared to a net...
FutureFuel Corp. Announces Notice of Deferred Ex-Dividend Date
Written by Customer Service on . Posted in Public Companies.
CLAYTON, Mo., March 24, 2020 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, announced on March 24, 2020 the deferral of the ex-dividend date on the special cash dividend of U.S. $3.00 per share on its common stock that FutureFuel declared on March 23, 2020 (the “Special Dividend”). Due to the size of the Special Dividend, the ex-date for the Special Dividend has been deferred until April 20, 2020 (i.e., the first business day after the payment date of the Special Dividend). If a person sells our stock before the ex-date, the Special Dividend associated with such stock sale will travel with the sale to the buyer. Alternatively, if a person buys our stock before the ex-date, the Special Dividend associated with such stock purchase will travel with the...
PeerStream, Inc. Renews Strategic Focus on Core Video Apps and Reports Full Year and Fourth Quarter 2019 Results
Written by Customer Service on . Posted in Public Companies.
Adopts Streamlined Plan of Operation, Right Sizes Spending and Reduces Total ExpensesNEW YORK, NY, March 24, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — PeerStream, Inc. (“PeerStream,” the “Company,” “we,” “our” or “us”) (OTCQB: PEER), a leading communications software innovator that powers multimedia social applications and developer of secure communications software, today announced financial and operational results for the fourth quarter and full year ended December 31, 2019.Jason Katz, Chairman and CEO of PeerStream, commented, “During the fourth quarter of 2019, the Company adopted a streamlined plan of operations, whereby we reduced operating expenses to better align with our revenue. Even after accounting for one-time severance costs incurred in the fourth quarter, we decreased total costs and expenses by over 13%, or...
CN to participate in a virtual fireside chat with BMO Capital Markets on March 26
Written by Customer Service on . Posted in Public Companies.
MONTREAL, March 24, 2020 (GLOBE NEWSWIRE) — JJ Ruest, President and Chief Executive Officer and Ghislain Houle, Executive Vice-President and Chief Financial Officer of CN (TSX: CNR) (NYSE: CNI), will participate in a virtual fireside chat hosted by Fadi Chamoun of BMO Capital Markets, on March 26, 2020 at 1:00 p.m. Eastern Time (ET).CN will provide a live audio webcast of their remarks via the Investors’ section of the Company’s website, www.cn.ca/en/investors.CN is a true backbone of the economy, transporting more than C$250 billion worth of goods annually for a wide range of business sectors, ranging from resource products to manufactured products to consumer goods, across a rail network of approximately 20,000 route-miles spanning Canada and mid-America. CN – Canadian National Railway Company, along with its operating railway...
Le CN participera à une discussion informelle avec un représentant de BMO Marchés des capitaux, le 26 mars 2020
Written by Customer Service on . Posted in Public Companies.
MONTRÉAL, 24 mars 2020 (GLOBE NEWSWIRE) — Jean-Jacques Ruest, président-directeur général du CN, et Ghislain Houle, vice-président exécutif et chef de la direction financière du CN (TSX : CNR) (NYSE : CNI), participeront à une discussion informelle animée par Fadi Chamoun de BMO Marchés des capitaux, le 26 mars 2020 à 13 h (heure de l’Est).On pourra suivre la diffusion audio en direct de la discussion à partir de la section « Investisseurs » du site Web du CN à l’adresse www.cn.ca/fr/investisseurs.Véritable pilier de l’économie, le CN transporte annuellement des marchandises d’une valeur de plus de 250 G$ CA pour un large éventail de secteurs, tels les ressources naturelles, les produits manufacturés et les biens de consommation, sur un réseau ferroviaire de quelque 20 000 milles de parcours couvrant le Canada et le centre des États-Unis....
Hingham Savings Notice of Annual Meeting
Written by Customer Service on . Posted in Public Companies.
HINGHAM, Mass., March 24, 2020 (GLOBE NEWSWIRE) — Our Annual Meeting of Shareholders is scheduled for Thursday, April 30th, 2020 at 4:00 PM at Old Derby Academy in Hingham, MA. Since the current management group took control of the Bank following a proxy fight in April 1993, this meeting has been an important event for our company and for me personally. It has provided an occasion for our “partnership” to gather, meet each other, and discuss the state of our business. Our entire Board of Directors, our management team, our lenders, and many of our employees attend. In recent years, an increasing number of other shareholders have attended and it has been a pleasure to meet them and introduce them to each other and to our team.Although our retail branch network currently remains open, we are implementing measures to reduce social...
Allakos Announces the Initiation of Antolimab (AK002) Clinical Studies
Written by Customer Service on . Posted in Public Companies.
Phase 3 study of antolimab for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis (previously referred to as eosinophilic gastroenteritis)Phase 2/3 study of antolimab for the treatment of eosinophilic esophagitisPhase 1 study of subcutaneously administered antolimab in healthy volunteers— Management to host conference call and webcast today at 5:00 pm ET —REDWOOD CITY, Calif., March 24, 2020 (GLOBE NEWSWIRE) — Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast cell related diseases, today reported the initiation of three clinical studies of antolimab: a Phase 3 study in eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD), a Phase 2/3 study in eosinophilic esophagitis (EoE), and a Phase 1 study of subcutaneously administered...
Fortress Transportation and Infrastructure Investors LLC Announces 2019 K-1 Tax Package
Written by Customer Service on . Posted in Public Companies.
NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) — Fortress Transportation and Infrastructure Investors LLC (“NYSE:FTAI”) today announced that its 2019 Schedule K-1 tax packages are available online. FTAI shareholders may access their Schedule K-1 tax packages at www.taxpackagesupport.com/FTAI or by visiting the Investor Center section of FTAI’s website at www.ftandi.com.The mailing of 2019 Schedule K-1 tax packages will commence before March 31, 2020. For additional information, shareholders may call FTAI Tax Package Support toll free at (855) 225-9906.About Fortress Transportation and Infrastructure Investors LLCFortress Transportation and Infrastructure Investors LLC owns and acquires high quality infrastructure and equipment that is essential for the transportation of goods and people globally. FTAI targets assets that, on a combined...
TSS, INC. REPORTS FOURTH QUARTER AND 2019 RESULTS
Written by Customer Service on . Posted in Public Companies.
ROUND ROCK, Texas, March 24, 2020 (GLOBE NEWSWIRE) — TSS, Inc. (Other OTC: TSSI), a data center facilities and technology services company, reported results for its fourth quarter and fiscal year ended December 31, 2019.Fourth Quarter Highlights:Fourth quarter 2019 revenue of $20.4 million compared with $5.7 million in the fourth quarter of 2018 and $4.2 million in the third quarter of 2019.Gross margin of 10% in the fourth quarter of 2019 compared with 35% in the fourth quarter of 2018.Achieved operating income of $440,000 in the fourth quarter of 2019 compared to operating income of $1,463,000 in the fourth quarter of 2018 and an operating loss of $12,000 in the third quarter of 2019. (Fourth quarter of 2018 included a gain of $1,140,000 from the sale of assets of our power and cooling solutions business in Virginia).Net income...
Allakos Announces Positive Phase 1 Results with Antolimab (AK002) in Mast Cell Gastrointestinal Disease
Written by Customer Service on . Posted in Public Companies.
— Antolimab (AK002) reduced gastrointestinal symptoms by 64 percent in patients with mast cell gastrointestinal disease —— Management to host conference call and webcast today at 5:00 pm ET —REDWOOD CITY, Calif., March 24, 2020 (GLOBE NEWSWIRE) — Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing antolimab (AK002) for the treatment of eosinophil and mast cell related diseases, today reported results from a Phase 1 study evaluating the safety and efficacy of antolimab for the treatment of patients with mast cell gastrointestinal disease.Mast Cell Gastrointestinal DiseaseDuring enrollment of the Company’s Phase 2 ENIGMA study in patients with eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD), patients were identified with chronic moderate to severe gastrointestinal symptoms and elevated...